✦ LIBER ✦

Comparative Safety of Filgrastim versus Sargramostim in Patients Receiving Myelosuppressive Chemotherapy

✍ Scribed by Mr. Gary Milkovich; Dr. Ronald J. Moleski; Dr. John F. Reitan; Dr. David M. Dunning; Dr. Gene A. Gibson; Dr. Thomas A. Paivanas; Dr. Susan Wyant; Mr. R. Jake Jacobs

Book ID: 115047883
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 48 KB
Volume: 20
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.20.19.1432.34861

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial comparing the tolerabil

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

✍ R. A. Beveridge; John A. Miller; Arthur N. Kales; Richard A. Binder; Nicholas J. 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 199 KB

Safety and Efficacy of Pegfilgrastim in

Safety and Efficacy of Pegfilgrastim in Patients Receiving Myelosuppressive Chemotherapy

✍ Jeffrey Crawford 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

A randomized double-blind multicenter ph

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

✍ Green, M. D. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 127 KB

Comparison of hospitalization risk and a

Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia

✍ Derek Weycker; Richard L. Barron 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Comparison of hospitalization risk and a

Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia

✍ Mark L. Heaney; Edmond L. Toy; Francis Vekeman; François Laliberté; Bree L. Dori 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

The safety and efficacy of day 1 versus

The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies

✍ Jenny M. Whitworth; Kellie S. Matthews; Kimberly A. Shipman; T. Michael Numnum; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB